scholarly journals Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease1

2018 ◽  
Vol 96 (4) ◽  
pp. 1259-1267 ◽  
Author(s):  
S Crosby ◽  
B Credille ◽  
S Giguère ◽  
R Berghaus
Keyword(s):  
High Risk ◽  
Antimicrobial Resistance ◽  
Respiratory Disease ◽  
Bovine Respiratory Disease ◽  
Mannheimia Haemolytica ◽  
Comparative Efficacy

Serotyping and antimicrobial resistance of Mannheimia haemolytica strains from European cattle with bovine respiratory disease

2019 ◽  
Vol 124 ◽  
pp. 10-12 ◽  
Author(s):  
Sara Andrés-Lasheras ◽  
Rahat Zaheer ◽  
Cassidy Klima ◽  
Haley Sanderson ◽  
Rodrigo Ortega Polo ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Respiratory Disease ◽  
Bovine Respiratory Disease ◽  
Mannheimia Haemolytica ◽  
European Cattle

scholarly journals Prevalence and Risk Factors Associated With Antimicrobial Resistance in Bacteria Related to Bovine Respiratory Disease—A Broad Cross-Sectional Study of Beef Cattle at Entry Into Canadian Feedlots

2021 ◽  
Vol 8 ◽  
Author(s):  
Sara Andrés-Lasheras ◽  
Reuben Ha ◽  
Rahat Zaheer ◽  
Catrione Lee ◽  
Calvin W. Booker ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Beef Cattle ◽  
Respiratory Disease ◽  
Bovine Respiratory Disease ◽  
Cross Sectional Study ◽  
Mannheimia Haemolytica ◽  
Mycoplasma Bovis ◽  
Sectional Study ◽  
Cross Sectional ◽  
Histophilus Somni

A broad, cross-sectional study of beef cattle at entry into Canadian feedlots investigated the prevalence and epidemiology of antimicrobial resistance (AMR) in Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis, bacterial members of the bovine respiratory disease (BRD) complex. Upon feedlot arrival and before antimicrobials were administered at the feedlot, deep nasopharyngeal swabs were collected from 2,824 feedlot cattle in southern and central Alberta, Canada. Data on the date of feedlot arrival, cattle type (beef, dairy), sex (heifer, bull, steer), weight (kg), age class (calf, yearling), source (ranch direct, auction barn, backgrounding operations), risk of developing BRD (high, low), and weather conditions at arrival (temperature, precipitation, and estimated wind speed) were obtained. Mannheimia haemolytica, P. multocida, and H. somni isolates with multidrug-resistant (MDR) profiles associated with the presence of integrative and conjugative elements were isolated more often from dairy-type than from beef-type cattle. Our results showed that beef-type cattle from backgrounding operations presented higher odds of AMR bacteria as compared to auction-derived calves. Oxytetracycline resistance was the most frequently observed resistance across all Pasteurellaceae species and cattle types. Mycoplasma bovis exhibited high macrolide minimum inhibitory concentrations in both cattle types. Whether these MDR isolates establish and persist within the feedlot environment, requires further evaluation.

scholarly journals PSVI-2 The effect of a recombinant Mannheimia haemolytica leukotoxoid on the health and growth performance of high-risk, newly received stocker cattle metaphylactically treated with tilmicosin

2019 ◽  
Vol 97 (Supplement_3) ◽  
pp. 196-197
Author(s):  
Autumn T Pickett ◽  
Jase Ball ◽  
Elizabeth Kegley ◽  
Ken Blue ◽  
Jacob A Hagenmaier ◽  
...  
Keyword(s):  
Body Weight ◽  
High Risk ◽  
Antibody Response ◽  
Growth Performance ◽  
Respiratory Disease ◽  
Bovine Respiratory Disease ◽  
Average Daily Gain ◽  
Mannheimia Haemolytica ◽  
Type I ◽  
Bovine Virus Diarrhea

Abstract Crossbred male beef calves (n = 259; bulls = 134, steers = 125; body weight = 250 ± 3.4 kg) approximately 6 months of age and considered high-risk for developing bovine respiratory disease arrived on 3 dates (block) and were stratified by arrival castrate status and weight to be evenly distributed across pens (8 pens/block; 9 to 12 calves/pen). The pens were randomly assigned to 1 of 2 treatments: 1) Nuplura PH (administration of a Mannheimia haemolytica leukotoxoid at processing) or 2) Control (no M. haemolytica leukotoxoid). All cattle received tilmicosin on d 0 with a 5-d post-metaphylactic interval. Body weights were recorded on d -1, 0, 14, 28, 41 and 42. Blood was collected on d -1, 14, 28, and 42 and sera were harvested to determine serum neutralization titers for bovine virus diarrhea (BVD) type I and bovine anti-M. haemolytica leukotoxin antibodies. Calves were observed daily for signs of morbidity. Body weight and average daily gain were not affected (P ≥ 0.26) by treatment. The percentage of calves administered 1, 2, or 3 antibiotic treatments for clinical bovine respiratory disease did not differ (P ≥ 0.35). There was a tendency for mortality to be greater for Control compared to Nuplura PH (1.6 vs 0.0%; P = 0.10). Calves administered Nuplura PH possessed greater antibody response against M. haemolytica leukotoxin on d 14, 28, and 42 compared to Control calves (P < 0.01). There was no treatment × day interaction for antibody titers against BVD (P = 0.98). The use of a M. haemolytica leukotoxoid had no effect on growth performance and morbidity for the 42-d following receiving in this small-pen study, but reduced the incidence of mortality and did not interfere with antibody response to BVD vaccination in high-risk, newly received calves metaphylactically treated with tilmicosin on arrival.

Comparison of Mannheimia haemolytica isolates from an outbreak of bovine respiratory disease

2016 ◽  
Vol 182 ◽  
pp. 82-86 ◽  
Author(s):  
S. Rainbolt ◽  
D.K. Pillai ◽  
B.V. Lubbers ◽  
M. Moore ◽  
R. Davis ◽  
...  
Keyword(s):  
Respiratory Disease ◽  
Bovine Respiratory Disease ◽  
Mannheimia Haemolytica

scholarly journals Development of Bacterial Therapeutics against the Bovine Respiratory Pathogen Mannheimia haemolytica

2019 ◽  
Vol 85 (21) ◽  
Author(s):  
Samat Amat ◽  
Edouard Timsit ◽  
Danica Baines ◽  
Jay Yanke ◽  
Trevor W. Alexander
Keyword(s):  
Respiratory Disease ◽  
Animal Health ◽  
Bovine Respiratory Disease ◽  
Feedlot Cattle ◽  
Mitigation Strategies ◽  
Commensal Bacteria ◽  
Mannheimia Haemolytica ◽  
Respiratory Pathogen ◽  
Content Type

ABSTRACT Bovine respiratory disease (BRD) is a major cause of morbidity and mortality in beef cattle. Recent evidence suggests that commensal bacteria of the bovine nasopharynx have an important role in maintaining respiratory health by providing colonization resistance against pathogens. The objective of this study was to screen and select bacterial therapeutic candidates from the nasopharynxes of feedlot cattle to mitigate the BRD pathogen Mannheimia haemolytica. In a stepwise approach, bacteria (n = 300) isolated from the nasopharynxes of 100 healthy feedlot cattle were identified and initially screened (n = 178 isolates from 12 different genera) for growth inhibition of M. haemolytica. Subsequently, selected isolates were evaluated for the ability to adhere to bovine turbinate (BT) cells (n = 47), compete against M. haemolytica for BT cell adherence (n = 15), and modulate gene expression in BT cells (n = 10). Lactobacillus strains had the strongest inhibition of M. haemolytica, with 88% of the isolates (n =33) having inhibition zones ranging from 17 to 23 mm. Adherence to BT cells ranged from 3.4 to 8.0 log10 CFU per 105 BT cells. All the isolates tested in competition assays reduced M. haemolytica adherence to BT cells (32% to 78%). Among 84 bovine genes evaluated, selected isolates upregulated expression of interleukin 8 (IL-8) and IL-6 (P < 0.05). After ranking isolates for greatest inhibition, adhesion, competition, and immunomodulation properties, 6 Lactobacillus strains from 4 different species were selected as the best candidates for further development as intranasal bacterial therapeutics to mitigate M. haemolytica infection in feedlot cattle. IMPORTANCE Bovine respiratory disease (BRD) is a significant animal health issue impacting the beef industry. Current BRD prevention strategies rely mainly on metaphylactic use of antimicrobials when cattle enter feedlots. However, a recent increase in BRD-associated bacterial pathogens that are resistant to metaphylactic antimicrobials highlights a pressing need for the development of novel mitigation strategies. Based upon previous research showing the importance of respiratory commensal bacteria in protecting against bronchopneumonia, this study aimed to develop bacterial therapeutics that could be used to mitigate the BRD pathogen Mannheimia haemolytica. Bacteria isolated from the respiratory tracts of healthy cattle were characterized for their inhibitory, adhesive, and immunomodulatory properties. In total, 6 strains were identified as having the best properties for use as intranasal therapeutics to inhibit M. haemolytica. If successful in vivo, these strains offer an alternative to metaphylactic antimicrobial use in feedlot cattle for mitigating BRD.

scholarly journals Genotypic antimicrobial resistance characterization of E. coli from dairy calves at high risk of respiratory disease administered enrofloxacin or tulathromycin

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
R. V. Pereira ◽  
C. Foditsch ◽  
J. D. Siler ◽  
S. C. Dulièpre ◽  
C. Altier ◽  
...  
Keyword(s):  
High Risk ◽  
Antimicrobial Resistance ◽  
Respiratory Disease ◽  
Resistance Genes ◽  
Tetracycline Resistance ◽  
Control Group ◽  
E Coli ◽  
Tetracycline Resistance Genes ◽  
Antimicrobial Resistance Genes

Abstract The objective of this study was to evaluate the longitudinal effect of enrofloxacin or tulathromycin use in calves at high risk of bovine respiratory disease (BRD) on antimicrobial resistance genes and mutation in quinolone resistance-determining regions (QRDR) in fecal E. coli. Calves at high risk of developing BRD were randomly enrolled in one of three groups receiving: (1) enrofloxacin (ENR; n = 22); (2) tulathromycin (TUL; n = 24); or (3) no treatment (CTL; n = 21). Fecal samples were collected at enrollment and at 7, 28, and 56 days after beginning treatment, cultured for Escherichiacoli (EC) and DNA extracted. Isolates were screened for cephalosporin, quinolone and tetracycline resistance genes using PCR. QRDR screening was conducted using Sanger sequencing. The only resistance genes detected were aac(6′)Ib-cr (n = 13), bla-CTX-M (n = 51), bla-TEM (n = 117), tetA (n = 142) and tetB (n = 101). A significantly higher detection of gyrA mutated at position 248 at time points 7 (OR = 11.5; P value = 0.03) and 28 (OR = 9.0; P value = 0.05) was observed in the ENR group when compared to calves in the control group. Our findings support a better understanding of the potential impacts from the use of enrofloxacin in calves on the selection and persistence of resistance.

Sign in / Sign up

Export Citation Format

Share Document